FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Philipp University of Marburg
Marburgo, AlemaniaPublicaciones en colaboración con investigadores/as de Philipp University of Marburg (12)
2024
-
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
Annals of Oncology, Vol. 35, Núm. 5, pp. 429-436
2023
-
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
Respiratory Research, Vol. 24, Núm. 1
-
Increased uptake of the P2X7 receptor radiotracer 18F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice
Epilepsia, Vol. 64, Núm. 2, pp. 511-523
-
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
Annals of Oncology
2021
-
Circulating p2x7 receptor signaling components as diagnostic biomarkers for temporal lobe epilepsy
Cells, Vol. 10, Núm. 9
-
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
Gut, Vol. 70, Núm. 2, pp. 319-329
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Pembrolizumab for early triple-negative breast cancer
New England Journal of Medicine, Vol. 382, Núm. 9, pp. 810-821
2016
-
Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel
Annals of Oncology, Vol. 27, Núm. 3, pp. 379-390
2009
-
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled european study of forsteo (EUROFORS)
Journal of Bone and Mineral Research, Vol. 24, Núm. 4, pp. 726-736
2008
-
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 3, pp. 852-860
-
Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment
Journal of Bone and Mineral Research, Vol. 23, Núm. 10, pp. 1591-1600